ECS Botanics (ASX:ECS) - Founder and MD, Alex Keach
Founder and MD, Alex Keach
Source: ECS Botanics
The Market Online - At The Bell

Join our daily newsletter At The Bell to receive exclusive market insights

  • ECS Botanics (ECS) is set to stock its Extra Virgin Tasmanian Hemp Seed Oil product in Coles stores nationwide
  • The product is expected to be on shelves in October and will be stocked in the cooking oil section
  • Hemp seed oil is becoming more popular due to its environmentally friendly source of Omega 3 and its anti-inflammatory properties
  • Total revenue is uncertain at this time and no minimum volumes have yet to be confirmed
  • Shares in ECS are up 9.09 per cent, trading at 3.6 cents at 12:44 pm AEST

ECS Botanics (ECS) is set to sell its Extra Virgin Tasmanian Hemp Seed Oil product in Coles stores nationwide.

The product will be stocked in a number of Coles’ 2500 stores from October.

ECS will no longer use Just Food Australia for the distribution of its products which allows it to achieve significantly higher margins.

The hemp seed oil product will be stocked in the cooking oil section of Coles. It can be used in cooking, salads, smoothies and baking.

Hemp seed oil is becoming more popular due to its environmental source of Omega 3 and its anti-inflammatory properties.

Total revenue is uncertain at this time and no minimum volumes have yet to be confirmed.

Managing Director Alex Keach is excited with the partnership and believes the product will be well received.

“We are delighted to be supplying Coles with our premium hemp seed oil product and are confident the product will be well received by consumers,” Mr Keach said.

“As the largest retail supplier of oil in the country, we are witnessing demand for hemp seed oil steadily increase and to now have the product stocked with two of Australia’s largest supermarket retailers, we are well positioned to capitalise on market demand.

“Now that we have established a direct relationship with supermarket groups, we will take advantage of the opportunity to extend the number of products ranged with these retailers.”

Shares in ECS were up 9.09 per cent, trading at 3.6 cents at 12:44 pm AEST.

ECS by the numbers
More From The Market Online

PharmAust CEO’s sayanora triggers stock plunge

Clinical-stage biotechnology company, PharmAust shares plunged 24 per cent so this morning, following the resignation of…

Emyria locks in $2.3M to progress MDMA research – with Chair adding $0.3M

WA-based and ASX-listed Emyria is seeking to further research using MDMA to treat PTSD. The chair…

Genetic Signatures wins TGA greenlight for flu test device – just before winter

Genetic Signatures (ASX:GSS) shares were down -1.45% to 68cps on Monday, even as the company reported…

PYC Therapeutics takes Polycystic Kidney Disease drug to human trials

PYC Therapeutics takes its latest drug for Polycystic Kidney Disease, characterized by the formation of cysts…